Streetbeat News

Analyst Ratings

ZURA

Guggenheim analyst Yatin Suneja initiates coverage on Zura Bio (NASDAQ:ZURA) with a Buy rating and announces a price target of $20.

Portfolio Pulse from richadhand@benzinga.com

June 22, 2023 | 1:28 pm

DRI

Stephens & Co. analyst Joshua Long reiterates an Overweight rating on Darden Restaurants (NYSE:DRI) and maintains a $170 price target.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 1:19 pm

DRI

TD Cowen analyst Andrew Charles reiterates an Outperform rating on Darden Restaurants (NYSE:DRI) and maintains a $160 price target.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 1:17 pm

CVX

NAT

VLO

Wall Street's most accurate analysts recommend buying energy stocks Nordic American Tankers Limited (NYSE:NAT), Chevron Corporation (NYSE:CVX), and Valero Energy Corporation (NYSE:VLO) due to their high dividend yields. These companies have strong free cash flows and reward shareholders with high dividend payouts.

Portfolio Pulse from Lisa Levin

June 22, 2023 | 1:15 pm

PFE

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Pfizer (NYSE:PFE) and maintained a $75 price target.

Portfolio Pulse from richadhand@benzinga.com

June 22, 2023 | 1:08 pm

HUMA

Cantor Fitzgerald analyst Kristen Kluska initiates coverage on Humacyte (NASDAQ:HUMA) with an Overweight rating and a price target of $6.

Portfolio Pulse from richadhand@benzinga.com

June 22, 2023 | 1:07 pm

ALNY

Cantor Fitzgerald analyst Olivia Brayer reiterated a Neutral rating on Alnylam Pharmaceuticals (NASDAQ:ALNY) and maintained a $200 price target.

Portfolio Pulse from richadhand@benzinga.com

June 22, 2023 | 1:05 pm

INTC

Mizuho analyst Vijay Rakesh reiterated a Neutral rating on Intel (NASDAQ:INTC) and maintained a $30 price target.

Portfolio Pulse from richadhand@benzinga.com

June 22, 2023 | 1:01 pm

ALDX

Analysts have provided bullish ratings for Aldeyra Therapeutics (NASDAQ:ALDX) within the last quarter, with an average price target of $17.5 compared to the current price of $7.72. The current average has decreased by 37.5% from the previous average price target of $28.00.

Portfolio Pulse from Benzinga Insights

June 22, 2023 | 1:01 pm

EGHT

Analysts have provided various ratings for 8x8 (NASDAQ:EGHT) within the last quarter, with an average price target of $5.56, implying an upside compared to the current price of $3.65. The average price target has increased by 11.87% over the past month.

Portfolio Pulse from Benzinga Insights

June 22, 2023 | 1:01 pm